Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates that target cancer signaling pathways.
Kura Oncology
TAP Partner
San Diego, California
United States
Project Title
Program
Therapy Acceleration Program